ADMA Biologics, Inc. (ADMA)

NASDAQ: ADMA · Real-Time Price · USD

11.75

+0.47 (4.17%)

At close: Oct 29, 2026, 4:00 PM EDT

11.70

-0.05 (-0.43%)

After-hours: Oct 29, 2026, 7:30 PM EDT

ADMA Biologics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	512.28	510.17	426.45	258.22	154.08	80.94
Revenue Growth	8.04%	19.63%	65.16%	67.58%	90.36%	91.72%
Gross Profit	331.47	292.77	219.55	88.94	35.27	1.17
Operating Income	216.5	191.44	138.98	22.33	-39.37	-57.57
Net Income	168.96	146.93	197.67	-28.24	-65.9	-71.65
Earnings Per Share	0.70	0.60	0.81	-0.13	-0.33	-0.51
EPS Growth	-17.00%	-25.93%	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
ADMA BioManufacturing	494.71	493	415.81	249.74	144.07	74.94
Plasma Collection Centers	-	17.03	10.51	8.33	9.87	5.86
License	0.14	0.14	0.14	0.14	0.14	0.14
Revenue (Total)	512.28	510.17	426.45	258.22	154.08	80.94

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	136.02	87.63	103.15	51.35	86.52	51.09
Total Debt	203.84	79.89	82.12	141.42	154.44	102.92
Net Cash (Debt)	-67.82	7.75	21.03	-90.07	-67.92	-51.83
Net Cash Growth	-	-63.17%	-	-	-	-
Net Cash Per Share	-0.28	0.03	0.09	-0.40	-0.34	-0.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	136.72	50.4	118.67	8.8	-59.51	-112.37
Capital Expenditures	-20.25	-22.58	-8.23	-4.77	-13.91	-13.51
Free Cash Flow	116.47	27.82	110.45	4.03	-73.42	-125.88
Free Cash Flow Growth	77.08%	-74.81%	2641.28%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.70%	57.38%	51.48%	34.45%	22.89%	1.45%
Operating Margin	42.26%	37.52%	32.59%	8.65%	-25.55%	-71.13%
Pretax Margin	42.26%	35.80%	29.48%	-10.94%	-42.77%	-88.52%
Profit Margin	32.98%	28.80%	46.35%	-10.94%	-42.77%	-88.52%
FCF Margin	22.74%	5.45%	25.90%	1.56%	-47.65%	-155.52%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.78	29.55	20.51	-	-	-
Forward PE	14.33	22.24	25.28	36.16	-	-
P/FCF Ratio	22.60	156.04	36.71	253.51	-	-
PS Ratio	5.14	8.51	9.51	3.96	5.56	3.41